10-Q · May 14, 2026
Identiv, Inc. reported Q1 2026 revenue of $7.4 million and a diluted EPS of -$0.15, exceeding revenue estimates but slightly missing EPS expectations. Compared to Q1 2025, revenue increased by 41% from $5.3 million…
Earnings analysis · 10-Q
INVE earnings analysis
Filed August 13, 2026 · Our reading of the company's report
The latest report
Q2 revenue of $5.681 million grew approximately 13% year over year, and the $0.20 diluted loss improved from a $0.26 loss in Q2 2025, but revenue declined from $7 million in Q1 2026 and missed consensus. The more…
Read full summary
Q2 revenue of $5.681 million grew approximately 13% year over year, and the $0.20 diluted loss improved from a $0.26 loss in Q2 2025, but revenue declined from $7 million in Q1 2026 and missed consensus. The more significant signal is the reduced Q3 revenue outlook of $4.1 million-$4.8 million, driven in part by a major customer’s inventory pause and expected chip delays in Q3 and Q4 2026. The proposed Asset Sale offers stated consideration of $50.0 million in Buyer preferred equity and a $25.0 million cash contribution, but introduces substantial closing, liquidity, transition and post-sale execution risks.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-0.2
What stood out
-
Revenue improved year over year
Q2 revenue was $5.681 million, approximately 13% above the $5.0 million reported in Q2 2025, but below the prior-quarter $7 million level.
-
Loss narrowed year over year
Reported diluted EPS was a $0.20 loss, compared with a $0.15 loss in Q1 2026 and a $0.26 loss in Q2 2025; the year-over-year loss narrowed by $0.06 per share.
-
Potential customer reordering later in 2026
Management indicated that a larger consumer-facing customer accumulated inventory over the last three quarters and paused new orders for several months, but expects ordering to resume later in 2026.
-
Asset sale provides substantial stated consideration
The proposed Asset Sale includes Buyer Series C Shares with an agreed value of $50.0 million, plus a planned $25.0 million cash contribution to Buyer, subject to adjustment.
-
No reported control deficiencies
Disclosure controls and procedures were concluded to be effective at the reasonable assurance level as of June 30, 2026, and the company reported no material changes to internal controls during the quarter.
What to watch
-
Near-term revenue outlook declined
Q3 FY2026 revenue guidance of $4.1 million-$4.8 million is below the prior $5.4 million-$6.0 million outlook. The company stated that the customer inventory pause will negatively affect third- and fourth-quarter results.
-
Supply delays and transaction costs
The company is experiencing significantly longer lead times with several chip suppliers and anticipates delays in certain chips during Q3 and Q4 2026. It also reported approximately $1.9 million of Asset Sale transaction-related expenses through June 30, 2026.
-
Asset Sale closing remains uncertain
The Asset Sale is subject to Required Stockholder Approval and other closing conditions, and termination in certain circumstances could require a $750,000 fee to Buyer.
-
Illiquid preferred equity consideration
The Buyer Series C Shares have an agreed value of $50.0 million but no current public market and transfer restrictions, so the company may not monetize the investment at the stated value or at all.
-
Execution risk in post-sale transition
Following the Asset Sale, the company may have no meaningful operations unless it completes acquisitions, with revenue potentially consisting solely of transition-service payments. It also expects to retain only a small group of employees and its CEO intends to resign after closing.
-
Cash deployment may constrain strategy
The company increased its share repurchase authorization to $40 million and intends to contribute $25.0 million in cash to Buyer. These uses could reduce resources available for acquisitions and ongoing public-company expenses.
Management's outlook
Management provided Q3 FY2026 revenue guidance of $4.1 million-$4.8 million, below the prior Q2 FY2026 outlook of $5.4 million-$6.0 million. Guidance excludes the potential Trackonomy asset-sale closing; no numeric EPS guidance was provided.
Earlier filings 2
10-K · April 29, 2026
Identiv, Inc. reported its financial performance for the fiscal year 2025, showcasing significant developments in revenue, gross margin, and executive compensation structures. Despite narrow losses, the positive…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.